ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
PepGen Inc

PepGen Inc (PEPG)

4.49
-0.06
(-1.32%)
Closed November 14 4:00PM
4.49
0.00
(0.00%)
After Hours: 4:18PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.49
Bid
2.28
Ask
4.70
Volume
141,293
4.425 Day's Range 5.01
3.81 52 Week Range 19.298
Market Cap
Previous Close
4.55
Open
4.77
Last Trade Time
Financial Volume
$ 657,744
VWAP
4.6552
Average Volume (3m)
105,608
Shares Outstanding
32,595,737
Dividend Yield
-
PE Ratio
-1.86
Earnings Per Share (EPS)
-2.41
Revenue
-
Net Profit
-78.63M

About PepGen Inc

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
PepGen Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PEPG. The last closing price for PepGen was $4.55. Over the last year, PepGen shares have traded in a share price range of $ 3.81 to $ 19.298.

PepGen currently has 32,595,737 shares outstanding. The market capitalization of PepGen is $148.31 million. PepGen has a price to earnings ratio (PE ratio) of -1.86.

PEPG Latest News

PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

– FREEDOM-DM1 data from 5 and 10 mg/kg cohorts in patients with DM1 expected in the first quarter of 2025 – – Study designs of CONNECT program optimized based on encouraging results from early...

PepGen to Participate in Upcoming Investor Conferences

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.66-37.20279720287.157.154.363573304.67727013CS
4-4.47-49.88839285718.969.154.361171695.38942964CS
12-5.48-54.96489468419.9710.144.361056087.66501063CS
26-9.21-67.226277372313.719.2984.3612308210.85877482CS
520.4210.31941031944.0719.2983.8111205811.10407958CS
156-11.11-71.217948717915.6203.7210681111.11031369CS
260-11.11-71.217948717915.6203.7210681111.11031369CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTEMMolecular Templates Inc
$ 0.60
(86.28%)
331.48M
QUBTQuantum Computing Inc
$ 4.43
(66.54%)
228.27M
OMEROmeros Corporation
$ 6.96
(66.11%)
14.19M
ADGMAdagio Medical Holdings Inc
$ 3.71
(57.87%)
2.65M
VVPRVivoPower International PLC
$ 1.18
(50.47%)
5.91M
SOWGSow Good Inc
$ 4.23
(-56.88%)
2.91M
WCTWellchange Holdings Company Limited
$ 4.08
(-48.35%)
1.27M
NVCTNuvectis Pharma Inc
$ 5.73
(-46.30%)
1.71M
KXINKaixin Holdings
$ 2.525
(-39.59%)
4.5M
TRNRInteractive Strength Inc
$ 3.59
(-38.42%)
1.25M
ELABElevai Labs Inc
$ 0.024658
(-0.17%)
1.81B
XTIAXTI Aerospace Inc
$ 0.0565
(-1.22%)
366.26M
MTEMMolecular Templates Inc
$ 0.60
(86.28%)
331.49M
SVMHSRIVARU Holding Ltd
$ 0.0268
(10.74%)
251.29M
QUBTQuantum Computing Inc
$ 4.43
(66.54%)
232.55M